The Nasdaq Biotechnology Index rose by 1%. UroGen Pharma ADR increased by 51.92%, CureVac NV ADR rose by 37.59%, and Fortrea Holdings climbed by 15.99%. Lexeo Therapeutics fell by 9.31%, MacroGenics decreased by 9.36%, and Fate Therapeutics dropped by 9.68%
The Nasdaq Biotechnology Index closed up 1%. Component stock UroGen Pharma ADR rose 51.92%, CureVac NV ADR increased by 37.59%, and Fortrea Holdings rose 15.99%, ranking third. Lexeo Therapeutics fell 9.31%, ranking third from the bottom, MacroGenics dropped 9.36%, and Fate Therapeutics declined 9.68%